• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-27作为结节性痒疹和大疱性类天疱疮瘙痒的新型生物标志物。

IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.

作者信息

Wang Yifei, Zhang Xin, Teng Yun Te, Shen Chen

机构信息

Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

出版信息

Front Immunol. 2024 Dec 13;15:1499868. doi: 10.3389/fimmu.2024.1499868. eCollection 2024.

DOI:10.3389/fimmu.2024.1499868
PMID:39735535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11681427/
Abstract

INTRODUCTION

Bullous pemphigoid (BP) and prurigo nodularis (PN) are chronic pruritic skin diseases that severely impact patients' quality of life. Despite the widespread attention these two diseases have garnered within the dermatological field, the specific pathogenesis, particularly the molecular mechanisms underlying the pruritus, remains largely unclear. Limited clinical sequencing studies focusing on BP and PN have hindered the identification of pathological mechanisms and the exploration of effective treatment strategies.

METHODS

To address this gap, we collected a total of 23 peripheral blood mononuclear cell samples from BP and PN patients, as well as healthy controls, and performed RNA sequencing analysis. By integrating bioinformatics and machine learning techniques, we aimed to uncover the shared immune regulatory networks and pruritus-related mechanisms between BP and PN.

RESULTS

Our study identified 161 differentially expressed genes shared between BP and PN, which were primarily enriched in immune activation and neural pathways, providing crucial molecular insights into the pruritus-related mechanisms of both diseases. Furthermore, using the machine learning algorithms of support vector machines and random forest, we pinpoint 7 crucial genes shared between the BP and PN databases. Among these, IL-27 emerged as a potential pivotal gene, as its mRNA expression levels strongly correlated with clinical parameters including pruritus scores, immunoglobulin E levels, and eosinophil counts. Validation experiments conducted on clinical samples from an additional 22 participants confirmed the upregulation of IL-27 expression in both BP and PN lesions.

DISCUSSION

This study is the first to unveil the shared inflammatory and immune pathways common to BP and PN, highlighting the critical role of IL-27 in the pathogenesis of these conditions. Our findings not only enhance the understanding of the intricate relationship between BP and PN, but also provide a foundation for the development of novel therapeutic strategies targeting these two dermatological conditions.

摘要

引言

大疱性类天疱疮(BP)和结节性痒疹(PN)是慢性瘙痒性皮肤病,严重影响患者的生活质量。尽管这两种疾病在皮肤科领域受到了广泛关注,但其具体发病机制,尤其是瘙痒背后的分子机制,在很大程度上仍不清楚。针对BP和PN的临床测序研究有限,阻碍了病理机制的识别和有效治疗策略的探索。

方法

为了填补这一空白,我们总共收集了23份来自BP和PN患者以及健康对照的外周血单个核细胞样本,并进行了RNA测序分析。通过整合生物信息学和机器学习技术,我们旨在揭示BP和PN之间共享的免疫调节网络和瘙痒相关机制。

结果

我们的研究确定了BP和PN之间共有的161个差异表达基因,这些基因主要富集于免疫激活和神经通路,为这两种疾病的瘙痒相关机制提供了关键的分子见解。此外,使用支持向量机和随机森林的机器学习算法,我们在BP和PN数据库之间确定了7个关键基因。其中,IL-27成为一个潜在的关键基因,因为其mRNA表达水平与包括瘙痒评分、免疫球蛋白E水平和嗜酸性粒细胞计数在内的临床参数密切相关。对另外22名参与者的临床样本进行的验证实验证实了BP和PN皮损中IL-27表达的上调。

讨论

本研究首次揭示了BP和PN共有的炎症和免疫通路,突出了IL-27在这些疾病发病机制中的关键作用。我们的发现不仅增进了对BP和PN之间复杂关系的理解,也为针对这两种皮肤病的新型治疗策略的开发提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/94a2c99727b2/fimmu-15-1499868-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/6d4b39bba0df/fimmu-15-1499868-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/7316b196ed4b/fimmu-15-1499868-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/0c0592dd2bb4/fimmu-15-1499868-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/f9585983b0c2/fimmu-15-1499868-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/3df0ea03688d/fimmu-15-1499868-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/2d22453131eb/fimmu-15-1499868-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/94a2c99727b2/fimmu-15-1499868-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/6d4b39bba0df/fimmu-15-1499868-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/7316b196ed4b/fimmu-15-1499868-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/0c0592dd2bb4/fimmu-15-1499868-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/f9585983b0c2/fimmu-15-1499868-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/3df0ea03688d/fimmu-15-1499868-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/2d22453131eb/fimmu-15-1499868-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc3/11681427/94a2c99727b2/fimmu-15-1499868-g007.jpg

相似文献

1
IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.白细胞介素-27作为结节性痒疹和大疱性类天疱疮瘙痒的新型生物标志物。
Front Immunol. 2024 Dec 13;15:1499868. doi: 10.3389/fimmu.2024.1499868. eCollection 2024.
2
A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.抗白细胞介素-31 受体 A 抗体治疗后发生大疱性类天疱疮 1 例。
J Dermatol. 2024 Sep;51(9):1252-1255. doi: 10.1111/1346-8138.17171. Epub 2024 Mar 20.
3
Unusual variants of pemphigoid: from pruritus to pemphigoid nodularis.类天疱疮的罕见变体:从瘙痒到结节性类天疱疮。
J Cutan Pathol. 1992 Jun;19(3):212-6. doi: 10.1111/j.1600-0560.1992.tb01661.x.
4
Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.大疱性类天疱疮和瘙痒性疾病老年患者的自身反应性外周血辅助性 T 细胞反应。
Front Immunol. 2021 Mar 25;12:569287. doi: 10.3389/fimmu.2021.569287. eCollection 2021.
5
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.结节性痒疹的病理生理学、诊断和药物治疗。
Expert Rev Clin Pharmacol. 2021 Jan;14(1):67-77. doi: 10.1080/17512433.2021.1852080. Epub 2020 Dec 11.
6
Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.大疱性类天疱疮患者的特征:经典大疱性类天疱疮与非大疱性类天疱疮的比较。
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):161-165. doi: 10.1111/jdv.15883. Epub 2019 Sep 5.
7
Molecular mechanisms of pruritus in prurigo nodularis.结节性痒疹瘙痒的分子机制。
Front Immunol. 2023 Nov 23;14:1301817. doi: 10.3389/fimmu.2023.1301817. eCollection 2023.
8
Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses.通过免疫印迹分析在瘙痒性皮肤病中检测到的类大疱性类天疱疮抗体的频率。
Arch Dermatol. 1992 Jun;128(6):791-4.
9
Interleukin Profiling in Atopic Dermatitis and Chronic Nodular Prurigo.特应性皮炎和慢性结节性痒疹的白细胞介素谱分析。
Int J Mol Sci. 2024 Aug 2;25(15):8445. doi: 10.3390/ijms25158445.
10
Nodular Subtype of Bullous Pemphigoid.大疱性类天疱疮的结节亚型
J Cutan Med Surg. 2016 Nov;20(6):570-572. doi: 10.1177/1203475416648322. Epub 2016 May 4.

本文引用的文献

1
Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets.瘙痒感觉的分子和细胞机制以及抗瘙痒药物靶点。
Acta Pharmacol Sin. 2025 Mar;46(3):539-553. doi: 10.1038/s41401-024-01400-x. Epub 2024 Oct 18.
2
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.尼莫利珠单抗联合局部治疗用于中重度特应性皮炎青少年和成人患者(ARCADIA 1 和 ARCADIA 2 研究):两项复制、双盲、随机对照 3 期临床试验结果。
Lancet. 2024 Aug 3;404(10451):445-460. doi: 10.1016/S0140-6736(24)01203-0. Epub 2024 Jul 24.
3
Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD).
血清白细胞介素-5 受体 (IL-5R) 浓度与慢性自发性荨麻疹 (CSU) 和特应性皮炎 (AD) 患者疾病严重程度的相关性。
Int J Mol Sci. 2024 Jul 11;25(14):7598. doi: 10.3390/ijms25147598.
4
Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases.超越经典参与者:Mas相关G蛋白偶联受体成员X2在瘙痒和皮肤病中的作用
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):476-486. doi: 10.1111/jdv.20249. Epub 2024 Jul 23.
5
Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease.单细胞转录组学分析揭示 2 型炎症性疾病中天疱疮的免疫-基质细胞串扰。
Nat Commun. 2024 Jul 15;15(1):5949. doi: 10.1038/s41467-024-50283-3.
6
Chronic Pruritus: A Review.慢性瘙痒症:综述。
JAMA. 2024 Jun 25;331(24):2114-2124. doi: 10.1001/jama.2024.4899.
7
Nemolizumab: a new key player in the treatment of prurigo nodularis.奈莫利珠单抗:结节性痒疹治疗中的新关键药物。
Br J Dermatol. 2024 Jul 16;191(2):154-155. doi: 10.1093/bjd/ljae189.
8
An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases.炎症性自身免疫性疾病中双功能 IL-27 的最新进展。
Front Immunol. 2024 Mar 19;15:1366377. doi: 10.3389/fimmu.2024.1366377. eCollection 2024.
9
Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.神经元 BST2:IL-27 驱动的瘙痒通路中与蛋白酶激活受体 2 一起的瘙痒介质。
J Invest Dermatol. 2024 Aug;144(8):1829-1842.e4. doi: 10.1016/j.jid.2024.01.025. Epub 2024 Feb 13.
10
IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis.IL-31 依赖性神经源性炎症抑制变应性性皮炎中的皮肤 2 型免疫反应。
Sci Immunol. 2023 Oct 20;8(88):eabi6887. doi: 10.1126/sciimmunol.abi6887. Epub 2023 Oct 13.